Superman 90mg is a dual PDE5 inhibitor oral tablet formulation combining Sildenafil and Tadalafil, supplied in a 50 tablet pack. Manufactured for consistent potency, stability, and controlled research applications.
Format50 Tablets
Concentration90mg(Viagra 65mg, Cialis 25mg)
Pay with Interac e-Transfer or Crypto
HPLC verified. COA on file for this batch
Ships from within Canada; No Customs
Discreet plain packaging; always
24h dispatch; Tracked Delivery
This formulation combines Sildenafil 65mg and Tadalafil 25mg in a single tablet, the lower concentration variant in CSD’s dual PDE5 inhibitor range alongside the Superman V2 130mg listing. As with Superman V2, both compounds act on the same PDE5 enzyme target through the same fundamental mechanism, meaning this is two inhibitors of the identical pathway rather than two independent or complementary mechanisms working together.
At 65mg Sildenafil and 25mg Tadalafil, this formulation sits below the standard maximum recommended dose for either compound individually (100mg Sildenafil, 20mg Tadalafil) on the Sildenafil side, but the Tadalafil component at 25mg already exceeds Tadalafil’s standard maximum of 20mg. This is a meaningfully different dose profile from the Superman V2 130mg variant, which delivers both components at or above their individual maximums. Superman 90mg represents a moderated version of the same dual inhibitor concept, though it still combines two PDE5 inhibitors acting on the same pathway simultaneously.
The same underlying consideration applies to combining any two PDE5 inhibitors regardless of the specific dose split; there is no established clinical evidence that combining Sildenafil and Tadalafil produces better outcomes than an adequate dose of either compound alone, since both compete for the same enzyme binding site rather than acting through separate mechanisms. The combined side effect burden, and the absolute nitrate interaction contraindication, apply to both compounds simultaneously regardless of dose.
Every batch of CSD’s Superman 90mg is third party lab tested for concentration accuracy and purity before being made available, with COA documentation available on request. CSD stocks two dual PDE5 inhibitor presentations: this 90mg and the higher concentration 130mg Superman V2 — for researchers specifically examining comparative dose response across combined PDE5 inhibitor formulations. All orders ship discreetly across Canada in plain, unmarked packaging with no identifying information on the exterior.
This product combines two PDE5 inhibitors. While the total dose is lower than the Superman V2 130mg variant, this combination still carries elevated side effect risk compared to either compound alone, and must not be combined with nitrate medications under any circumstances. Strongly consult a healthcare provider before considering this product, particularly if you have any cardiovascular conditions, take other medications, or have not previously used either compound individually.
Store in a cool, dry place away from direct light and heat.
Superman 90mg is a dual PDE5 inhibitor combination tablet delivering Sildenafil Citrate 65mg and Tadalafil 25mg in a single oral dose; a more conservative formulation than the Superman V2 130mg which contains 110mg Sildenafil and 20mg Tadalafil. The Superman 90mg formulation uses a lower Sildenafil dose (65mg versus 110mg) reducing the fast acting component's intensity, while using a slightly higher Tadalafil dose (25mg versus 20mg) slightly extending the sustained duration component beyond the standard 20mg Tadalafil maximum approved dose. This configuration produces a more balanced dual PDE5 profile, less aggressive rapid onset peak from Sildenafil, with marginally extended duration from the higher Tadalafil component.
The Superman 90mg formulation offers several practical advantages over the higher dose V2 version. The 65mg Sildenafil component produces meaningful rapid onset PDE5 inhibition within 30–60 minutes with a lower incidence of Sildenafil dose dependent side effects: headache, flushing, and visual disturbances are less pronounced at 65mg than at 110mg. The 25mg Tadalafil component provides sustained 36 hour background PDE5 inhibition. The combined 90mg total tablet dose is more manageable for researchers with cardiovascular sensitivity or those new to dual PDE5 inhibitor research, producing robust combined PDE5 inhibition with a more tolerable haemodynamic profile than the maximum dose V2 formulation.
Sildenafil alone produces rapid onset within 30–60 minutes but limited 4–6 hour duration, requiring precise timing and offering no extended coverage beyond the immediate research window. Tadalafil alone has a slightly slower onset but provides 36 hour sustained PDE5 inhibition. The Superman 90mg combination delivers both pharmacokinetic profiles simultaneously. Sildenafil's rapid onset initiation alongside Tadalafil's extended duration, producing a research profile no single PDE5 inhibitor can replicate. This dual coverage is particularly valuable for research protocols requiring both immediate and sustained PDE5 inhibition without the inconvenience of administering two separate compounds.
Administer orally 30–60 minutes before the research window, the Sildenafil component drives onset timing and benefits from fasted or light meal administration for fastest absorption. High fat meals significantly delay Sildenafil absorption, fasted administration produces the most predictable onset. The organic nitrate contraindication applies absolutely to this combination, severe hypotension risk is significantly elevated with dual PDE5 inhibition alongside any nitrate compound. Researchers assessing cardiovascular tolerance for the first time may prefer to start with a half tablet delivering approximately 32.5mg Sildenafil and 12.5mg Tadalafil before committing to the full dose.
Yes! This batch has been independently HPLC tested by an accredited third party laboratory confirming concentration accuracy at 65mg Sildenafil Citrate and 25mg Tadalafil per tablet and correct compound identity for both active components. A certificate of analysis is available.
![Tobramycin 0.3% and Dexamethsone 0.1% 5mL eye drops | CANADIAN PHARMA GRADE - [PINK EYE / EYE INFECTION]](https://www.canadasteroiddepot.is/wp-content/uploads/2026/08/TobraDex-5mL-300x300.png.webp)
